News
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
‘What The Fat?’, co-authored by Caryn Zinn, Craig Rodger, and Grant Schofield, highlights a low-carb, healthy-fat diet, and is held up as an effective weight loss tool. Dr Zinn joined Kerre Woodham ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industr ...
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts. It's become available ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.
Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...
Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next year, its CEO said on Tuesday, the latest Chinese company to join the race ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results